Af­ter near­ly two years of crit­i­cism from ac­tivists and White House, Mod­er­na un­veils a new plan for glob­al health

Mod­er­na, the tar­get of near­ly two years of crit­i­cism for its poli­cies around glob­al ac­cess to its Covid-19 vac­cine, an­nounced on Mon­day a new plan to ad­dress glob­al health.

The mR­NA biotech said it would launch a four-part pro­gram. First, it would put vac­cines in­to clin­i­cal test­ing for 15 pathogens that could ei­ther cause fu­ture pan­demics, such as Ni­pah virus or Zi­ka, or that pri­mar­i­ly af­fect the de­vel­op­ing world, such as tu­ber­cu­lo­sis and malar­ia.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.